Review



d code dgge complete system  (Bio-Rad)


Bioz Verified Symbol Bio-Rad is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 88

    Structured Review

    Bio-Rad d code dgge complete system
    Fig. 2 <t>DGGE</t> profiles of amplified 16S rDNA from mucosal bacterial samples of HCT patients. DGGE profiles of amplified 16S rDNA from mucosal bacterial samples of HCT patients are shown. a Quinolone prophylaxis and/or β- lactam monotherapy group. b β- Lactam-glycopeptide combination therapy group. bfr, before HCT sample; aft, after HCT sample. Intense bands (a a– ao, b a–z) were sequenced, and bacterial species identified from the sequence data are shown in Table 2. M, marker
    D Code Dgge Complete System, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 88/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/d code dgge complete system/product/Bio-Rad
    Average 88 stars, based on 6 article reviews
    d code dgge complete system - by Bioz Stars, 2026-04
    88/100 stars

    Images

    1) Product Images from "Unusual oral mucosal microbiota after hematopoietic cell transplantation with glycopeptide antibiotics: potential association with pathophysiology of oral mucositis."

    Article Title: Unusual oral mucosal microbiota after hematopoietic cell transplantation with glycopeptide antibiotics: potential association with pathophysiology of oral mucositis.

    Journal: Folia microbiologica

    doi: 10.1007/s12223-018-0596-1

    Fig. 2 DGGE profiles of amplified 16S rDNA from mucosal bacterial samples of HCT patients. DGGE profiles of amplified 16S rDNA from mucosal bacterial samples of HCT patients are shown. a Quinolone prophylaxis and/or β- lactam monotherapy group. b β- Lactam-glycopeptide combination therapy group. bfr, before HCT sample; aft, after HCT sample. Intense bands (a a– ao, b a–z) were sequenced, and bacterial species identified from the sequence data are shown in Table 2. M, marker
    Figure Legend Snippet: Fig. 2 DGGE profiles of amplified 16S rDNA from mucosal bacterial samples of HCT patients. DGGE profiles of amplified 16S rDNA from mucosal bacterial samples of HCT patients are shown. a Quinolone prophylaxis and/or β- lactam monotherapy group. b β- Lactam-glycopeptide combination therapy group. bfr, before HCT sample; aft, after HCT sample. Intense bands (a a– ao, b a–z) were sequenced, and bacterial species identified from the sequence data are shown in Table 2. M, marker

    Techniques Used: Amplification, Glycoproteomics, Sequencing, Marker



    Similar Products

    88
    Bio-Rad d code dgge complete system
    Fig. 2 <t>DGGE</t> profiles of amplified 16S rDNA from mucosal bacterial samples of HCT patients. DGGE profiles of amplified 16S rDNA from mucosal bacterial samples of HCT patients are shown. a Quinolone prophylaxis and/or β- lactam monotherapy group. b β- Lactam-glycopeptide combination therapy group. bfr, before HCT sample; aft, after HCT sample. Intense bands (a a– ao, b a–z) were sequenced, and bacterial species identified from the sequence data are shown in Table 2. M, marker
    D Code Dgge Complete System, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/d code dgge complete system/product/Bio-Rad
    Average 88 stars, based on 1 article reviews
    d code dgge complete system - by Bioz Stars, 2026-04
    88/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 2 DGGE profiles of amplified 16S rDNA from mucosal bacterial samples of HCT patients. DGGE profiles of amplified 16S rDNA from mucosal bacterial samples of HCT patients are shown. a Quinolone prophylaxis and/or β- lactam monotherapy group. b β- Lactam-glycopeptide combination therapy group. bfr, before HCT sample; aft, after HCT sample. Intense bands (a a– ao, b a–z) were sequenced, and bacterial species identified from the sequence data are shown in Table 2. M, marker

    Journal: Folia microbiologica

    Article Title: Unusual oral mucosal microbiota after hematopoietic cell transplantation with glycopeptide antibiotics: potential association with pathophysiology of oral mucositis.

    doi: 10.1007/s12223-018-0596-1

    Figure Lengend Snippet: Fig. 2 DGGE profiles of amplified 16S rDNA from mucosal bacterial samples of HCT patients. DGGE profiles of amplified 16S rDNA from mucosal bacterial samples of HCT patients are shown. a Quinolone prophylaxis and/or β- lactam monotherapy group. b β- Lactam-glycopeptide combination therapy group. bfr, before HCT sample; aft, after HCT sample. Intense bands (a a– ao, b a–z) were sequenced, and bacterial species identified from the sequence data are shown in Table 2. M, marker

    Article Snippet: For DGGE analyses, the amplicons and DGGE marker I (Nippon Gene, Tokyo, Japan) were electrophoresed using a D-code DGGE complete system (Bio-Rad, Hercules, CA) operated at 60 °C for 12 h at 100 V in a linear 25–65% denaturing agent gradient (100% denaturing agent consisted of 7mol/L urea and 40% deionized formamide) with 8% polyacrylamide gels (polyacrylamide gel, ratio of acrylamide HG (Wako Pure Chemical Industries, Osaka, Japan) to bisacrylamide (Wako Pure Chemical Industries), 37.5:1).

    Techniques: Amplification, Glycoproteomics, Sequencing, Marker